Annual Working Capital
$83.82 M
+$6.53 M+8.45%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual working capital is $83.82 million, with the most recent change of +$6.53 million (+8.45%) on December 31, 2023.
- During the last 3 years, ELEV annual working capital has risen by +$9.82 million (+13.27%).
- ELEV annual working capital is now -40.40% below its all-time high of $140.63 million, reached on December 31, 2021.
Performance
ELEV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$99.40 M
-$11.41 M-10.30%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly working capital is $99.40 million, with the most recent change of -$11.41 million (-10.30%) on September 30, 2024.
- Over the past year, ELEV quarterly working capital has stayed the same.
- ELEV quarterly working capital is now -35.97% below its all-time high of $155.24 million, reached on June 30, 2021.
Performance
ELEV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ELEV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.4% | 0.0% |
| 3 y3 years | +13.3% | +28.6% |
| 5 y5 years | +6264.4% | +28.6% |
ELEV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | +8.4% | -29.3% | +59.5% |
| 5 y | 5-year | -40.4% | +6264.4% | -36.0% | +59.5% |
| alltime | all time | -40.4% | +6264.4% | -36.0% | +59.5% |
Elevation Oncology Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $99.40 M(-10.3%) |
| Jun 2024 | - | $110.81 M(+5.0%) |
| Mar 2024 | - | $105.55 M(+25.9%) |
| Dec 2023 | $83.82 M(+8.5%) | $83.82 M(-8.1%) |
| Sep 2023 | - | $91.19 M(-9.7%) |
| Jun 2023 | - | $101.01 M(+62.1%) |
| Mar 2023 | - | $62.30 M(-19.4%) |
| Dec 2022 | $77.28 M | $77.28 M(-18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $94.97 M(-9.2%) |
| Jun 2022 | - | $104.59 M(-15.5%) |
| Mar 2022 | - | $123.81 M(-12.0%) |
| Dec 2021 | $140.63 M(+90.0%) | $140.63 M(-6.0%) |
| Sep 2021 | - | $149.56 M(-3.7%) |
| Jun 2021 | - | $155.24 M(+126.8%) |
| Mar 2021 | - | $68.44 M(-7.5%) |
| Dec 2020 | $74.00 M(+5518.9%) | $74.00 M |
| Dec 2019 | $1.32 M | - |
FAQ
- What is Elevation Oncology annual working capital?
- What is the all time high annual working capital for Elevation Oncology?
- What is Elevation Oncology annual working capital year-on-year change?
- What is Elevation Oncology quarterly working capital?
- What is the all time high quarterly working capital for Elevation Oncology?
- What is Elevation Oncology quarterly working capital year-on-year change?
What is Elevation Oncology annual working capital?
The current annual working capital of ELEV is $83.82 M
What is the all time high annual working capital for Elevation Oncology?
Elevation Oncology all-time high annual working capital is $140.63 M
What is Elevation Oncology annual working capital year-on-year change?
Over the past year, ELEV annual working capital has changed by +$6.53 M (+8.45%)
What is Elevation Oncology quarterly working capital?
The current quarterly working capital of ELEV is $99.40 M
What is the all time high quarterly working capital for Elevation Oncology?
Elevation Oncology all-time high quarterly working capital is $155.24 M
What is Elevation Oncology quarterly working capital year-on-year change?
Over the past year, ELEV quarterly working capital has changed by $0.00 (0.00%)